anmelden
AstraZeneca Aktie
147,60
EUR
-0,75
EUR
-0,51
%
146,75
EUR
-1,20
EUR
-0,81
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
AstraZeneca Aktie Analyse
| 01.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.11.17 | AstraZeneca Reduce | HSBC | |
| 23.10.17 | AstraZeneca Neutral | UBS AG | |
| 20.10.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 18.10.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 17.10.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.10.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.10.17 | AstraZeneca Outperform | Credit Suisse Group | |
|
Werbung
|
|||
| 11.10.17 | AstraZeneca buy | Deutsche Bank AG | |
| 09.10.17 | AstraZeneca Neutral | UBS AG | |
| 09.10.17 | AstraZeneca Reduce | HSBC | |
| 25.09.17 | AstraZeneca Outperform | BNP PARIBAS | |
| 22.09.17 | AstraZeneca Outperform | Bernstein Research | |
| 19.09.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 13.09.17 | AstraZeneca overweight | Barclays Capital | |
| 13.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.09.17 | AstraZeneca Neutral | UBS AG | |
| 11.09.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.09.17 | AstraZeneca Neutral | BNP PARIBAS | |
| 11.09.17 | AstraZeneca buy | Citigroup Corp. | |
| 11.09.17 | AstraZeneca buy | Deutsche Bank AG | |
| 11.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.09.17 | AstraZeneca Neutral | Credit Suisse Group | |
| 11.09.17 | AstraZeneca Reduce | HSBC | |
| 11.09.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 07.09.17 | AstraZeneca buy | Citigroup Corp. | |
| 05.09.17 | AstraZeneca buy | Deutsche Bank AG | |
| 01.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 31.08.17 | AstraZeneca Neutral | UBS AG | |
| 30.08.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 24.08.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 18.08.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.08.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 08.08.17 | AstraZeneca Reduce | HSBC | |
| 02.08.17 | AstraZeneca buy | Deutsche Bank AG | |
| 02.08.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.08.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 01.08.17 | AstraZeneca Neutral | UBS AG | |
| 31.07.17 | AstraZeneca buy | Citigroup Corp. | |
| 31.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.07.17 | AstraZeneca buy | Citigroup Corp. | |
| 28.07.17 | AstraZeneca kaufen | Kepler Cheuvreux | |
| 28.07.17 | AstraZeneca buy | Deutsche Bank AG | |
| 28.07.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.07.17 | AstraZeneca neutral | Credit Suisse Group | |
| 27.07.17 | AstraZeneca Hold | S&P Capital IQ | |
| 27.07.17 | AstraZeneca Neutral | UBS AG | |
Werbung
Werbung